NaNose Medical
Leveraging nanotechnology and AI for early disease detection and improved healthcare.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does NaNose Medical do?
NaNose Medical develops non-invasive, AI-driven sensing technology for early disease diagnosis and management using breath biomarkers. Their portable handheld device, Dianose, offers rapid, accurate, and affordable screening for conditions like chronic liver disease (ReLiV) and lung cancer (LUCIA). The company serves patients and healthcare professionals by enabling early action and intensive monitoring to improve outcomes and save lives.
Where is NaNose Medical headquartered?
NaNose Medical is headquartered in Tel Aviv, Israel.
When was NaNose Medical founded?
NaNose Medical was founded in 2017.
What industry does NaNose Medical operate in?
NaNose Medical operates in Healthcare, Medical Devices, Artificial Intelligence, HealthTech, MedTech, Nanotechnology.
How many employees does NaNose Medical have?
NaNose Medical has approximately 15 people on record.